» Articles » PMID: 15500908

The Gene Transcription Factor Cyclic AMP-responsive Element Binding Protein: Role in Positive and Negative Affective States of Alcohol Addiction

Overview
Journal Pharmacol Ther
Specialty Pharmacology
Date 2004 Oct 27
PMID 15500908
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The gene transcription factor cyclic adenosine monophosphate (cAMP)-responsive element binding (CREB) protein is a nuclear protein that regulates synaptic plasticity via modulating the expression of several (cAMP)-inducible genes. Alcohol addiction is a complex psychiatric disorder and is characterized by a compulsive and uncontrolled pattern of alcohol drinking by an individual in spite of the adverse consequences of its abuse. Ethanol produces both euphoric (reward and reinforcing) and dysphoric (negative withdrawal reactions) effects and these are most likely involved in the initiation and maintenance of alcohol use and abuse. Several neurotransmitter systems in the brain might be involved in the effects of alcohol but the exact molecular mechanisms of both the positive and negative affective states of alcohol abuse are still unclear. Recent research in molecular neurosciences using animal models have identified the role of extended amygdaloid (shell structures of nucleus accumbens [NAc] and central and medial amygdaloid nuclei) CREB signaling in positive and negative affective states of alcohol drinking behaviors. This review article highlights the current findings on the role of nucleus accumbal and amygdaloid CREB signaling in behavioral consequences of alcohol use and abuse.

Citing Articles

Emotional Expression on Social Media Support Forums for Substance Cessation: Observational Study of Text-Based Reddit Posts.

Yang G, King S, Lin H, Goldstein R J Med Internet Res. 2023; 25:e45267.

PMID: 37467010 PMC: 10398365. DOI: 10.2196/45267.


Alcohol Use Disorder: Neurobiology and Therapeutics.

Yang W, Singla R, Maheshwari O, Fontaine C, Gil-Mohapel J Biomedicines. 2022; 10(5).

PMID: 35625928 PMC: 9139063. DOI: 10.3390/biomedicines10051192.


CB1 receptor neutral antagonist treatment epigenetically increases neuropeptide Y expression and decreases alcohol drinking.

Dulman R, Zhang H, Banerjee R, Krishnan H, Dong B, Hungund B Neuropharmacology. 2021; 195:108623.

PMID: 34048869 PMC: 8410648. DOI: 10.1016/j.neuropharm.2021.108623.


Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities.

Namba M, Leyrer-Jackson J, Nagy E, Olive M, Neisewander J Front Neurosci. 2021; 15:650785.

PMID: 33935636 PMC: 8082184. DOI: 10.3389/fnins.2021.650785.


Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Koob G Pharmacol Rev. 2020; 73(1):163-201.

PMID: 33318153 PMC: 7770492. DOI: 10.1124/pharmrev.120.000083.